ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000254397.1	ABT-263 (navitoclax)	Colon adenocarcinoma	0.040671238	Resistant
ENSG00000254397.1	ABT-263 (navitoclax)	Sarcoma	0.040068821	Resistant